Nektar Therapeutics Presents Data On Rezpegaldesleukin From Its Phase 2b REZOLVE-A, Phase 2b REZOLVE-AD Trials At European Academy Of Dermatology And Venereology

Benzinga

2026.10.01 11:33 (GMT+0)

Benzingaで開く